Article Versions Notes

Cui Y, Yan H, Wang H, Zhang Y, Li M, Cui K, Xiao Z, Liu L, Xie W. CuS-¹³¹I-PEG Nanotheranostics-Induced “Multiple Mild-Hyperthermia” Strategy to Overcome Radio-Resistance in Lung Cancer Brachytherapy. Pharmaceutics. 2022; 14(12):2669. https://doi.org/10.3390/pharmaceutics14122669

Cui, Yanna, Hui Yan, Haoze Wang, Yongming Zhang, Meng Li, Kai Cui, Zeyu Xiao, Liu Liu, and Wenhui Xie. 2022. "CuS-¹³¹I-PEG Nanotheranostics-Induced “Multiple Mild-Hyperthermia” Strategy to Overcome Radio-Resistance in Lung Cancer Brachytherapy" Pharmaceutics 14, no. 12: 2669. https://doi.org/10.3390/pharmaceutics14122669

Cui, Y., Yan, H., Wang, H., Zhang, Y., Li, M., Cui, K., Xiao, Z., Liu, L., & Xie, W. (2022). CuS-¹³¹I-PEG Nanotheranostics-Induced “Multiple Mild-Hyperthermia” Strategy to Overcome Radio-Resistance in Lung Cancer Brachytherapy. Pharmaceutics, 14(12), 2669. https://doi.org/10.3390/pharmaceutics14122669